CONFERENCE ON THE ROLE OF IMMUNODEFICIENCY IN CANCER

免疫缺陷-癌症登记中心的调查人员和工作人员寻求 为举办一次关于免疫缺陷和癌症的作用的会议提供资金。这个 拟议的晚间会议将与一年一度的 儿科研究会和美国儿科学会春季会议 1986年5月在华盛顿特区进行的临床调查。该计划的目的是 会议将(1)提供有关几个主要项目的最新信息 与免疫缺陷和癌症之间的联系有关的话题 以及(2)探讨与慢性阻塞性肺疾病患者的相关性 自然发生的免疫缺陷谁发展成肿瘤，到癌症 患有医源性或获得性免疫抑制的患者以及 “看似”无免疫缺陷的人。案例材料来自 免疫缺陷-癌症登记处将提供讨论介绍 肿瘤的病理生理学、细胞遗传学和病毒学的相关性 在自然发生和治疗诱导的患者中 免疫缺陷。几个领域的专家(例如，流行病学、 遗传学、病毒学和/或分子生物学)，他们也有 免疫缺陷患者或他们的肿瘤，将被邀请制作 关于最新技术和未来发展方向的正式报告。 几位有过免疫缺陷癌症治疗经验的临床医生 将邀请东道主作为讨论者(报告员)。人们希望， 与会者，主要是临床研究人员，将获得新的热情 研究未来的患者材料，新的合作 基础科学家、病理学家和临床医生将紧随其后 免疫缺陷-癌症登记处，以及非营利性机构 免疫缺陷基金会的组织将促进这些 事态的发展。

The investigators and staff of the Immunodeficiency-Cancer Registry seek funds to host a conference on the role of immunodeficiency and cancer. The proposed evening conference will be held in conjunction with the annual spring meetings of the Society for Pediatric Research and the Society of Clinical Investigation in Washington D.C., May 1986. The purpose of the conference will be (1) to provide up-to-date information on several major topics pertaining to the association between immunodeficiency and cancer and (2) to explore the relevance of studies in patients with naturally-occurring immunodeficiencies who develop tumors, to cancer in patients with iatrogeneic or acquired immunosuppression as well as "seemingly" nonimmunodeficient persons. Case material from the Immunodeficiency-Cancer Registry will provide an introduction to discussion of the pathophysiological, cytogenetic, and virologic correlates of tumors in patients with naturally-occurring as well as therapy-induced immunodeficiencies. Experts in several areas (e.g., epidemiology, genetics, virology, and/or molecular biology), who have also had experience with immunodeficient patients or their tumors, will be invited to make formal presentations on the state-of-the art and future directions. Several clinicians who have had experience with cancer in immunodeficient hosts will be invited as discussants (rapporteurs). It is hoped that attendees, primarily clinical researchers, will gain new enthusiasm for studying prospective patient material, that new collaborations between basic scientists, pathologists, and clinicians will follow, and that the Immunodeficiency-Cancer Registry, as well as the nonprofit lay organization, Immunodeficiency Foundation, will facilitate these developments.